{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:46:21Z","timestamp":1791359181229,"version":"4.3.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.atherosclerosis.2021.11.018","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T10:59:23Z","timestamp":1637924363000},"page":"160-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian population"],"prefix":"10.1016","volume":"349","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5593-907X","authenticated-orcid":false,"given":"Wann Jia","family":"Loh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuling","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7814-8836","authenticated-orcid":false,"given":"Tar Choon","family":"Aw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon Kieng","family":"Phua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian F.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Yan-Yee","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7309-9473","authenticated-orcid":false,"given":"Chew-Kiat","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.atherosclerosis.2021.11.018_bib1","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.11.018_bib2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.11.018_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Emerging Risk Factors","year":"2009","journal-title":"J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.11.018_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","article-title":"Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study","volume":"117","author":"Kamstrup","year":"2008","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2021.11.018_bib5","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies","volume":"102","author":"Danesh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.11.018_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12944-016-0258-8","article-title":"The relationship between Lp(a) and CVD outcomes: a systematic review","volume":"15","author":"Forbes","year":"2016","journal-title":"Lipids Health Dis."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.11.018_bib7","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-8587(17)30088-8","article-title":"Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis","volume":"5","author":"Saleheen","year":"2017","journal-title":"Lancet Diabetes. Endocrinol."},{"key":"10.1016\/j.atherosclerosis.2021.11.018_bib8","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2741\/4635","article-title":"Lipoprotein(a) and cardiovascular disease: current state and future directions for an enigmatic lipoprotein","volume":"23","author":"Saeed","year":"2018","journal-title":"Front Biosci (Landmark Ed)."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.11.018_bib9","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk","volume":"139","author":"O'Donoghue","year":"2019","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2021.11.018_bib10","first-page":"e65","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"Reply. N Engl J Med."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2021.11.018_bib11","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.11.018_bib12","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa674","article-title":"Lipid management in patients with endocrine disorders: an endocrine society clinical practice guideline","volume":"105","author":"Newman","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.11.018_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1172\/JCI115855","article-title":"Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations","volume":"90","author":"Boerwinkle","year":"1992","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.11.018_bib14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/ATVBAHA.116.308704","article-title":"Lipoprotein(a) mass levels increase significantly according to APOE genotype: an analysis of 431 239 patients","volume":"37","author":"Moriarty","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.11.018_bib15","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","article-title":"Lipoprotein(a) levels and the risk of myocardial infarction among 7 ethnic groups","volume":"139","author":"Pare","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.11.018_bib16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/BF00201550","article-title":"Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups","volume":"86","author":"Sandholzer","year":"1991","journal-title":"Hum. Genet."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.11.018_bib17","doi-asserted-by":"crossref","first-page":"17921","DOI":"10.1038\/s41598-017-18214-z","article-title":"Genome-wide association study identifies a missense variant at APOA5 for coronary artery disease in Multi-Ethnic Cohorts from Southeast Asia","volume":"7","author":"Han","year":"2017","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2021.11.018_bib18","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.11.018_bib19","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1172\/JCI110941","article-title":"Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS)","volume":"71","author":"Ringqvist","year":"1983","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2021.11.018_bib20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2019.08.015","article-title":"Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays","volume":"289","author":"Scharnagl","year":"2019","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2021.11.018_bib21","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jacc.2012.12.023","article-title":"Extreme lipoprotein(a) levels and improved cardiovascular risk prediction","volume":"61","author":"Kamstrup","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.11.018_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","article-title":"Lp(a) (Lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national Biobank","volume":"41","author":"Patel","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.11.018_bib23","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20182096","article-title":"Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels","volume":"39","author":"Cai","year":"2019","journal-title":"Biosci. Rep."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.11.018_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8122073","article-title":"Molecular, population, and clinical aspects of lipoprotein(a): a bridge too far?","volume":"8","author":"Ward","year":"2019","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.11.018_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clinbiochem.2007.10.004","article-title":"Correlation between lipoprotein(a) serum concentration and severity of coronary artery stenosis in an Iranian population according to Gensini score","volume":"41","author":"Boroumand","year":"2008","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.11.018_bib26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1479164115579004","article-title":"Role of lipoprotein(a) in predicting the severity of new on-set coronary artery disease in type 2 diabetics: a Gensini score evaluation","volume":"12","author":"Chen","year":"2015","journal-title":"Diabetes Vasc. Dis. Res."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.11.018_bib27","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.hlc.2018.05.190","article-title":"Plasma lipoprotein(a) concentration is associated with the coronary severity but not with events in stable coronary artery disease patients: a Chinese cohort study","volume":"28","author":"Zhou","year":"2019","journal-title":"Heart Lung Circ."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.11.018_bib28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jacc.2013.09.042","article-title":"Lipoprotein(a) for risk assessment in patients with established coronary artery disease","volume":"63","author":"O'Donoghue","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.11.018_bib29","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S2213-8587(17)30096-7","article-title":"Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study","volume":"5","author":"Zewinger","year":"2017","journal-title":"Lancet Diabetes. Endocrinol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.11.018_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/003130299105034","article-title":"Serum lipoprotein(A) profiles in a Singaporean population","volume":"31","author":"Wong","year":"1999","journal-title":"Pathology"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2021.11.018_bib31","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1203\/00006450-199611000-00011","article-title":"Racial variation of cord plasma lipoprotein(a) levels in relation to coronary risk level: a study in three ethnic groups in Singapore","volume":"40","author":"Low","year":"1996","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.11.018_bib32","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI115645","article-title":"Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease","volume":"89","author":"Sandholzer","year":"1992","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.11.018_bib33","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/clinchem\/39.7.1382","article-title":"Quantification of lipoprotein(a) particles containing various apolipoprotein(a) isoforms by a monoclonal anti-apo(a) capture antibody and a polyclonal anti-apolipoprotein B detection antibody sandwich enzyme immunoassay","volume":"39","author":"Taddei-Peters","year":"1993","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.11.018_bib34","doi-asserted-by":"crossref","first-page":"291954","DOI":"10.1155\/2011\/291954","article-title":"Racial and ethnic variation in lipoprotein (a) levels among Asian Indian and Chinese patients","volume":"2011","author":"Banerjee","year":"2011","journal-title":"J. Lipids"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.11.018_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCULATIONAHA.116.024611","article-title":"LPA gene, ethnicity, and cardiovascular events","volume":"135","author":"Lee","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.11.018_bib36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.R061648","article-title":"Lipoprotein (a) measurements for clinical application","volume":"57","author":"Marcovina","year":"2016","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.11.018_bib37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/HCO.0000000000000842","article-title":"Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology","volume":"36","author":"Page","year":"2021","journal-title":"Curr. Opin. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.11.018_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227054","article-title":"Lipoprotein(a) plasma levels are not associated with survival after acute coronary syndromes: an observational cohort study","volume":"15","author":"Roth","year":"2020","journal-title":"PLoS One"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021014465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021014465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:49:55Z","timestamp":1758156595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021014465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":38,"alternative-id":["S0021915021014465"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.11.018","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian population","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}